{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:36:20Z","timestamp":1770748580791,"version":"3.50.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jconrel.2021.03.023","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:26:03Z","timestamp":1616513163000},"page":"76-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy"],"prefix":"10.1016","volume":"333","author":[{"given":"Shaoqun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengying","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.03.023_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1076\/opep.5.3.143.8364","article-title":"The global impact of eye injuries","volume":"5","author":"Negrel","year":"1998","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0161-6420(83)34387-6","article-title":"Penetrating ocular injuries - types of injuries and visual results","volume":"90","author":"Dejuan","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.eye.6700194","article-title":"Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology","volume":"16","author":"Charteris","year":"2002","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.eye.6702332","article-title":"Vitreoretinal surgery after childhood ocular trauma","volume":"21","author":"Sheard","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000101928","article-title":"Traumatic pediatric retinal detachment following open globe injury","volume":"221","author":"Wang","year":"2007","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00417-015-3087-y","article-title":"Pediatric open-globe injuries: clinical characteristics and factors associated with poor visual and anatomical success","volume":"254","author":"Sul","year":"2016","journal-title":"Graef. Arch. Clin. Exp."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0035","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-9394(14)71132-8","article-title":"A system for classifying mechanical injuries of the eye (globe). The ocular trauma classification group","volume":"123","author":"Pieramici","year":"1997","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004397-200207000-00015","article-title":"Proliferative vitreoretinopathy after trauma","volume":"42","author":"Kruger","year":"2002","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0045","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0161-6420(97)30167-5","article-title":"Post traumatic proliferative vitreoretinopathy - the epidemiologic profile, onset, risk factors, and visual outcome","volume":"104","author":"Cardillo","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ophtha.2013.06.045","article-title":"Retinal detachment after open globe injury","volume":"121","author":"Stryjewski","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bjophthalmol-2015-307347","article-title":"Triamcinolone during pars plana vitrectomy for open globe trauma: a pilot randomised controlled clinical trial","volume":"100","author":"Banerjee","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09273940802687838","article-title":"Vitreous concentration of triamcinolone Acetonide after a single Transseptal depot injection","volume":"17","author":"Silva","year":"2009","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2013.09.022","article-title":"Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-epsilon-caprolactone matrix","volume":"10","author":"Meng","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.actbio.2016.04.014","article-title":"Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-epsilon-caprolactone (PCL)","volume":"37","author":"Sun","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0075","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers-Basel"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2012.09.004","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0085","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.12-11460","article-title":"Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0039-6028(01)01297-3","article-title":"Does UV irradiation affect polymer properties relevant to tissue engineering?","volume":"491","author":"Fischbach","year":"2001","journal-title":"Surf. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/026248931103000503","article-title":"The effect of polymer molecular weight and UV radiation on physical properties and bioactivities of PCL films","volume":"30","author":"Yeh","year":"2011","journal-title":"Cell. Polym."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/app.24692","article-title":"Degradation of poly(L-lactide) films under ultraviolet-induced photografting and sterilization conditions","volume":"106","author":"Janorkar","year":"2007","journal-title":"Journal of Applied Polymer Science"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0105","series-title":"Assessing Ocular Toxicology in Laboratory Animals","first-page":"23","article-title":"Assessment of ocular toxicity potential: Basic theory and techniques","author":"Munger","year":"2013"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bjo.2009.172106","article-title":"Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection","volume":"94","author":"Nan","year":"2010","journal-title":"Brit. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/aos.12694","article-title":"Perioperative pharmacological management of choroidal detachment associated with rhegmatogenous retinal detachment","volume":"94","author":"Shen","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1167\/iovs.09-3672","article-title":"Intravitreal crystalline drug delivery for intraocular proliferation diseases","volume":"51","author":"Cheng","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0130","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1167\/iovs.15-16526","article-title":"A novel approach of Daunorubicin application on formation of proliferative retinopathy using a porous silicon controlled delivery system: pharmacodynamics","volume":"56","author":"Hou","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02150154","article-title":"Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye","volume":"225","author":"Hida","year":"1987","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0140","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jcrs.2017.08.010","article-title":"Clinical implication of triamcinolone in aqueous humor after depository sub-Tenon application","volume":"43","author":"Xu","year":"2017","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0145","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone Acetonide after a single 40-mg posterior Subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0150","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2003.039917","article-title":"An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy","volume":"88","author":"Cardillo","year":"2004","journal-title":"Brit. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0155","article-title":"Intravitreal pirfenidone inhibits post traumatic proliferative vitreoretinopathy","volume":"57","author":"Hazra","year":"2016","journal-title":"Invest Ophth Vis Sci"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0160","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/eye.2017.21","article-title":"Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy","volume":"31","author":"Khanum","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0165","first-page":"165","article-title":"Clinical management of proliferative vitreoretinopathy an update","volume":"35","author":"Khan","year":"2015","journal-title":"Retina-J. Ret. Vit. Dis."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00156419","article-title":"Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-Fu","volume":"19","author":"Borhani","year":"1995","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0175","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","article-title":"Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin study group","volume":"126","author":"Wiedemann","year":"1998","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0180","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.ophtha.2004.05.036","article-title":"A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy","volume":"111","author":"Charteris","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0185","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ophtha.2006.08.042","article-title":"Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy","volume":"114","author":"Wickham","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1167\/iovs.09-3672","article-title":"Intravitreal crystalline drug delivery for intraocular proliferation diseases","volume":"51","author":"Cheng","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","article-title":"Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology","volume":"211","author":"Andres-Guerrero","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0205","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1167\/iovs.05-1540","article-title":"A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis","volume":"47","author":"Gilger","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0210","first-page":"770","article-title":"Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants","volume":"27","author":"Okabe","year":"2007","journal-title":"Retina-J. Ret. Vit. Dis."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1463-5224.2010.00807.x","article-title":"Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis","volume":"13","author":"Gilger","year":"2010","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jop.2017.0121","article-title":"Intravitreal, subretinal, and suprachoroidal injections: evolution of microneedles for drug delivery","volume":"34","author":"Hartman","year":"2018","journal-title":"J. Ocul. Pharmacol. Th"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10856-006-0100-3","article-title":"Study on the shape memory effects of poly(L-lactide-co-epsilon-caprolactone) biodegradable polymers","volume":"19","author":"Lu","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jmbbm.2012.01.003","article-title":"Synthesis, structure and properties of poly(L-lactide-co-epsilon-caprolactone) statistical copolymers","volume":"9","author":"Fernandez","year":"2012","journal-title":"J. Mech. Behav. Biomed."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0240","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/pola.22031","article-title":"Fast degradable poly(L-lactide-co-epsilon-caprolactone) microspheres for tissue engineering: synthesis, characterization, and degradation behavior","volume":"45","author":"Garkhal","year":"2007","journal-title":"J. Polym. Sci. A Polym. Chem."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1381-5148(96)00081-8","article-title":"In vitro degradation of poly(caprolactone), poly(lactide) and their block copolymers: influence of composition, temperature and morphology","volume":"32","author":"Ye","year":"1997","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0250","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archopht.1989.01070020543036","article-title":"Refractive changes after scleral buckling surgery","volume":"107","author":"Smiddy","year":"1989","journal-title":"Arch. Ophthalmol. Chic."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0255","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1111\/aos.12420","article-title":"Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema","volume":"92","author":"Kim","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0260","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon\u2019s infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial","volume":"46","author":"Bonini","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/bm049921i","article-title":"Morphology of elastic poly(L-lactide-co-epsilon-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds","volume":"5","author":"Jeong","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0270","first-page":"1160","article-title":"Infectious endophthalmitis after glaucoma drainage implant surgery clinical features, microbial Spectrum, and outcomes","volume":"37","author":"Zheng","year":"2017","journal-title":"Retina-J. Ret. Vit. Dis."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0275","first-page":"214","article-title":"Erosion and intrusion of silicone rubber scleral buckle - presentation and management","volume":"21","author":"Nguyen","year":"2001","journal-title":"Retina-J. Ret. Vit. Dis."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0280","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0039-128X(00)00235-X","article-title":"Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids","volume":"66","author":"Jaffuel","year":"2001","journal-title":"Steroids"},{"key":"10.1016\/j.jconrel.2021.03.023_bb0285","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"Scott","year":"2009","journal-title":"Arch. Ophthalmol. Chic."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0290","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ajo.2011.10.021","article-title":"Pharmacokinetic study of vitreous and serum concentrations of triamcinolone Acetonide after posterior sub-Tenon\u2019s injection","volume":"153","author":"Kovacs","year":"2012","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.03.023_bb0295","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ajo.2009.03.031","article-title":"Systemic absorption of triamcinolone Acetonide after posterior sub-Tenon injection","volume":"148","author":"Zaka-Ur-Rab","year":"2009","journal-title":"Am J. Ophthalmol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:54:41Z","timestamp":1759161281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":59,"alternative-id":["S0168365921001346"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}